DARBEPOETIN ALFA

DARBEPOETIN ALFA was reported 54073 times

DARBEPOETIN ALFA is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VASCULAR ANASTOMOTIC HAEMORRHAGE 27 0.9000
1 APPENDICOLITH 290 0.7494
2 ANTACID THERAPY 89 0.6846
3 SLEEP DISORDER THERAPY 125 0.6313
4 SHUNT STENOSIS 134 0.4838
5 ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE 120 0.4781
6 ANALGESIC THERAPY 138 0.4299
7 DRUG THERAPY 135 0.3982
8 ARTERIOVENOUS FISTULA SITE COMPLICATION 238 0.3967
9 ANTICOAGULANT THERAPY 90 0.3169
10 VENA CAVA INJURY 28 0.3043
11 PERINEAL CYST 22 0.3014
12 CONGENITAL HIATUS HERNIA 64 0.2807
13 HEART FAILURE WITH PRESERVED EJECTION FRACTION 81 0.2755
14 MALIGNANT MELANOMA STAGE 0 55 0.2632
15 ANTI-ERYTHROPOIETIN ANTIBODY NEGATIVE 22 0.2418
16 APLASIA PURE RED CELL 808 0.2346
17 CENTRAL NERVOUS SYSTEM LUPUS 47 0.2108
18 PERITONEAL DIALYSIS 174 0.2104
19 SHUNT OCCLUSION 106 0.2087
20 BODY MASS INDEX ABNORMAL 46 0.1885
21 RENAL CYST HAEMORRHAGE 42 0.1858
22 ARTERIOVENOUS FISTULA SITE INFECTION 25 0.1852
23 ARTERIOVENOUS FISTULA OPERATION 49 0.1815
24 BACTEROIDES INFECTION 41 0.1571
25 INVESTIGATION 491 0.1565
26 RETICULOCYTE COUNT DECREASED 62 0.1439
27 TRANSPLANT 324 0.1363
28 MINERAL SUPPLEMENTATION 55 0.1228
29 REFRACTORY CYTOPENIA WITH UNILINEAGE DYSPLASIA 24 0.1212
30 HAEMODIALYSIS 994 0.1182
31 ARTERIOVENOUS FISTULA THROMBOSIS 39 0.1127
32 HYPERPHOSPHATAEMIA 201 0.0934
33 INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM 28 0.0924
34 ABDOMINAL WALL HAEMORRHAGE 24 0.0920
35 SKIN FIBROSIS 44 0.0909
36 SEROSITIS 49 0.0886
37 VASCULAR COMPRESSION 27 0.0854
38 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 56 0.0854
39 BLOOD PHOSPHORUS INCREASED 227 0.0831
40 DELAYED GRAFT FUNCTION 51 0.0717
41 ERYTHROPOIESIS ABNORMAL 21 0.0686
42 PALLIATIVE CARE 101 0.0659
43 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 60 0.0647
44 INTERVERTEBRAL DISC SPACE NARROWING 47 0.0583
45 RENAL TRANSPLANT 184 0.0509
46 INTERCEPTED PRODUCT ADMINISTRATION ERROR 386 0.0503
47 DIALYSIS 692 0.0487
48 HAEMOGLOBIN ABNORMAL 313 0.0486
49 NEPHROGENIC SYSTEMIC FIBROSIS 147 0.0486
50 TERMINAL STATE 320 0.0478
51 RENAL ARTERY STENOSIS 62 0.0450
52 AORTIC CALCIFICATION 25 0.0430
53 IRON DEFICIENCY 188 0.0418
54 HOSPITALISATION 6211 0.0404
55 IRON OVERLOAD 43 0.0398
56 EXTREMITY CONTRACTURE 25 0.0391
57 BONE MARROW DEPRESSION 38 0.0389
58 ENCEPHALOMALACIA 21 0.0373
59 JOINT CONTRACTURE 40 0.0373
60 CAROTID ARTERIOSCLEROSIS 38 0.0368
61 PRIMARY SEQUESTRUM 33 0.0364
62 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 179 0.0353
63 LYMPHOCELE 23 0.0346
64 AORTIC DILATATION 38 0.0342
65 PARVOVIRUS B19 INFECTION 30 0.0335
66 COMPLICATIONS OF TRANSPLANTED KIDNEY 75 0.0330
67 APPENDICITIS 306 0.0327
68 BLOOD URIC ACID INCREASED 189 0.0327
69 HYPERPARATHYROIDISM SECONDARY 81 0.0323
70 TOTAL LUNG CAPACITY DECREASED 51 0.0319
71 SKIN INDURATION 66 0.0318
72 HAEMOGLOBIN INCREASED 144 0.0315
73 RECTAL PROLAPSE 38 0.0315
74 LIVING IN RESIDENTIAL INSTITUTION 59 0.0314
75 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1052 0.0311
76 LUPUS NEPHRITIS 58 0.0310
77 ANAEMIA OF CHRONIC DISEASE 27 0.0299
78 AORTIC STENOSIS 103 0.0295
79 CARDIAC OUTPUT DECREASED 25 0.0283
80 TRANSFUSION 284 0.0271
81 AORTIC ARTERIOSCLEROSIS 68 0.0264
82 RENAL TRANSPLANT FAILURE 26 0.0263
83 HEMIANOPIA 26 0.0262
84 AZOTAEMIA 104 0.0260
85 HYPOPHOSPHATAEMIA 191 0.0258
86 MARASMUS 38 0.0250
87 PLEURITIC PAIN 69 0.0250
88 MEAN CELL VOLUME INCREASED 64 0.0249
89 INTERMITTENT CLAUDICATION 39 0.0246
90 SKIN HYPERTROPHY 68 0.0242
91 OSTEOSCLEROSIS 38 0.0241
92 OSTEOLYSIS 49 0.0239
93 TRANSFUSION REACTION 21 0.0239
94 NEPHROGENIC ANAEMIA 111 0.0239
95 VENTRICULAR FIBRILLATION 260 0.0234
96 HYPERPARATHYROIDISM 46 0.0223
97 MYASTHENIA GRAVIS 180 0.0223
98 CARDIOGENIC SHOCK 318 0.0221
99 CATHETER RELATED INFECTION 22 0.0217
100 MYELODYSPLASTIC SYNDROME 311 0.0215
101 BENIGN PROSTATIC HYPERPLASIA 104 0.0201
102 LUNG OPACITY 53 0.0201
103 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 21 0.0198
104 FIBROSIS 60 0.0195
105 RENAL FAILURE CHRONIC 149 0.0194
106 RENAL ATROPHY 24 0.0192
107 INTENSIVE CARE 27 0.0190
108 DEATH 16296 0.0189
109 REHABILITATION THERAPY 72 0.0186
110 PRODUCT STORAGE ERROR 1623 0.0185
111 HEPATOSPLENOMEGALY 47 0.0183
112 ACTINIC KERATOSIS 47 0.0181
113 SERUM FERRITIN INCREASED 91 0.0172
114 END STAGE RENAL DISEASE 305 0.0167
115 NORMOCHROMIC NORMOCYTIC ANAEMIA 50 0.0166
116 RESPIRATORY SYMPTOM 47 0.0165
117 DIVERTICULUM INTESTINAL 72 0.0164
118 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 67 0.0164
119 LEG AMPUTATION 67 0.0162
120 HAEMOGLOBIN DECREASED 1664 0.0162
121 KIDNEY TRANSPLANT REJECTION 77 0.0160
122 BLOOD PARATHYROID HORMONE INCREASED 46 0.0158
123 AORTIC VALVE STENOSIS 28 0.0157
124 MULTIPLE MYELOMA 73 0.0156
125 BREATH SOUNDS ABNORMAL 77 0.0156
126 SPONDYLOLISTHESIS 27 0.0155
127 TROPONIN INCREASED 117 0.0154
128 CALCIPHYLAXIS 28 0.0153
129 ASCITES 446 0.0152
130 CATHETER PLACEMENT 28 0.0151
131 TRANSPLANT FAILURE 36 0.0147
132 MULTIPLE ORGAN DYSFUNCTION SYNDROME 413 0.0146
133 BONE LESION 52 0.0144
134 BICYTOPENIA 28 0.0143
135 BLOOD CALCIUM INCREASED 125 0.0142
136 KYPHOSIS 25 0.0141
137 FEBRILE BONE MARROW APLASIA 60 0.0141
138 GOUT 253 0.0141
139 LEFT VENTRICULAR HYPERTROPHY 60 0.0140
140 BLOOD IRON INCREASED 25 0.0133
141 PYELONEPHRITIS ACUTE 26 0.0132
142 OCCULT BLOOD POSITIVE 26 0.0132
143 SPINAL OSTEOARTHRITIS 114 0.0130
144 EXPOSED BONE IN JAW 28 0.0129
145 BACTERIAL INFECTION 241 0.0129
146 BONE MARROW DISORDER 39 0.0129
147 KIDNEY FIBROSIS 21 0.0121
148 HYPERLIPIDAEMIA 143 0.0120
149 SKIN TIGHTNESS 56 0.0119
150 APLASTIC ANAEMIA 62 0.0119
151 FLUID OVERLOAD 172 0.0118
152 BLOOD TEST ABNORMAL 165 0.0117
153 ATELECTASIS 112 0.0116
154 PERITONITIS 240 0.0116
155 PERIODONTITIS 25 0.0115
156 ANAEMIA 2197 0.0115
157 LOBAR PNEUMONIA 21 0.0113
158 SQUAMOUS CELL CARCINOMA OF SKIN 68 0.0113
159 RENAL DISORDER 523 0.0112
160 FOETAL GROWTH RESTRICTION 68 0.0112
161 BLOOD BICARBONATE DECREASED 21 0.0111
162 HAEMATOCRIT DECREASED 217 0.0109
163 DEVICE RELATED SEPSIS 22 0.0109
164 ESCHERICHIA URINARY TRACT INFECTION 46 0.0108
165 BLOOD POTASSIUM INCREASED 174 0.0107
166 OSTEITIS 27 0.0107
167 LUMBAR SPINAL STENOSIS 31 0.0106
168 RENAL CYST 84 0.0106
169 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 180 0.0105
170 AORTIC VALVE INCOMPETENCE 44 0.0103
171 LOOSE TOOTH 33 0.0102
172 HAEMOLYSIS 79 0.0102
173 LUNG INFILTRATION 90 0.0102
174 ULCER 162 0.0102
175 POLYCYTHAEMIA 21 0.0102
176 HYPERKALAEMIA 356 0.0101
177 ARTERIOSCLEROSIS 95 0.0101
178 LOWER RESPIRATORY TRACT INFECTION 446 0.0098
179 HYPERURICAEMIA 40 0.0097
180 JAW FRACTURE 21 0.0097
181 LICHENOID KERATOSIS 22 0.0096
182 LARGE INTESTINE POLYP 66 0.0095
183 ENTEROCOCCAL INFECTION 46 0.0095
184 BONE MARROW FAILURE 192 0.0094
185 STAPHYLOCOCCAL BACTERAEMIA 41 0.0094
186 DIABETIC COMPLICATION 24 0.0094
187 ESCHERICHIA BACTERAEMIA 22 0.0093
188 LACUNAR INFARCTION 22 0.0092
189 CARDIOMEGALY 112 0.0091
190 PLEURAL EFFUSION 554 0.0091
191 DIASTOLIC DYSFUNCTION 28 0.0091
192 CARDIAC FAILURE ACUTE 60 0.0090
193 NEURALGIA 213 0.0088
194 SPINAL STENOSIS 36 0.0087
195 HYPOVOLAEMIA 51 0.0087
196 METASTASES TO SPINE 29 0.0086
197 TRICUSPID VALVE INCOMPETENCE 68 0.0086
198 SEPSIS 954 0.0085
199 PATHOLOGICAL FRACTURE 43 0.0085
200 AGRANULOCYTOSIS 157 0.0084
201 THERAPEUTIC RESPONSE DECREASED 512 0.0084
202 TACHYARRHYTHMIA 21 0.0084
203 CARDIAC VALVE DISEASE 48 0.0084
204 CACHEXIA 43 0.0083
205 METASTATIC NEOPLASM 36 0.0083
206 ASPIRATION 91 0.0083
207 CLOSTRIDIUM DIFFICILE COLITIS 88 0.0083
208 CEREBRAL ATROPHY 33 0.0083
209 THROMBOPHLEBITIS 29 0.0083
210 MONOCYTE COUNT INCREASED 30 0.0083
211 RENAL IMPAIRMENT 694 0.0083
212 CHEMOTHERAPY 31 0.0082
213 HYPERCHOLESTEROLAEMIA 79 0.0082
214 RED BLOOD CELL COUNT DECREASED 233 0.0081
215 HYPONATRAEMIA 458 0.0081
216 TRANSPLANT REJECTION 64 0.0080
217 GANGRENE 48 0.0080
218 IRON DEFICIENCY ANAEMIA 73 0.0079
219 VENOUS THROMBOSIS 31 0.0079
220 GASTROENTERITIS 115 0.0079
221 HIP FRACTURE 253 0.0079
222 PERIPHERAL ISCHAEMIA 32 0.0078
223 HYPOCALCAEMIA 147 0.0078
224 RALES 45 0.0077
225 SPINAL COMPRESSION FRACTURE 64 0.0077
226 ECCHYMOSIS 53 0.0077
227 DUODENAL ULCER HAEMORRHAGE 22 0.0077
228 LOW BIRTH WEIGHT BABY 61 0.0077
229 THROMBOSIS IN DEVICE 25 0.0076
230 DECUBITUS ULCER 62 0.0076
231 MYELOFIBROSIS 23 0.0076
232 ENDOCARDITIS 39 0.0076
233 DERMATITIS EXFOLIATIVE 38 0.0076
234 BLOOD CREATININE INCREASED 489 0.0075
235 DIVERTICULUM 53 0.0075
236 OSTEOMYELITIS 135 0.0074
237 BLOOD ALBUMIN DECREASED 59 0.0074
238 BK VIRUS INFECTION 25 0.0074
239 PREMATURE DELIVERY 118 0.0074
240 ATRIOVENTRICULAR BLOCK FIRST DEGREE 32 0.0074
241 PANCYTOPENIA 412 0.0074
242 BONE DISORDER 134 0.0073
243 STAPHYLOCOCCAL SEPSIS 36 0.0073
244 HYPERVOLAEMIA 36 0.0073
245 CARDIAC FAILURE CHRONIC 31 0.0073
246 ESCHERICHIA SEPSIS 21 0.0072
247 CARDIAC FAILURE 579 0.0072
248 CEREBRAL ISCHAEMIA 37 0.0072
249 MITRAL VALVE INCOMPETENCE 81 0.0071
250 BLOOD CALCIUM DECREASED 80 0.0071
251 TOE AMPUTATION 36 0.0071
252 HEPATIC CYST 24 0.0071
253 DIABETIC RETINOPATHY 24 0.0071
254 REFUSAL OF TREATMENT BY PATIENT 46 0.0070
255 PROTHROMBIN TIME PROLONGED 42 0.0070
256 SPLENOMEGALY 82 0.0070
257 DEVICE RELATED INFECTION 107 0.0069
258 ACUTE PULMONARY OEDEMA 39 0.0069
259 PELVIC FRACTURE 54 0.0069
260 ANGINA UNSTABLE 45 0.0069
261 BILE DUCT STONE 22 0.0069
262 BACTERAEMIA 82 0.0069
263 ORTHOPNOEA 22 0.0069
264 CAROTID ARTERY STENOSIS 24 0.0069
265 MASTICATION DISORDER 21 0.0069
266 BRONCHIECTASIS 46 0.0068
267 THROMBOCYTOPENIA 759 0.0068
268 ATRIOVENTRICULAR BLOCK 52 0.0067
269 HEPATIC LESION 29 0.0067
270 PYELONEPHRITIS 58 0.0067
271 OCCUPATIONAL EXPOSURE TO PRODUCT 43 0.0067
272 GINGIVITIS 36 0.0067
273 HAEMATURIA 228 0.0067
274 HYPERCALCAEMIA 82 0.0066
275 BLOOD CREATINE INCREASED 29 0.0065
276 FAILURE TO THRIVE 34 0.0065
277 BLOOD COUNT ABNORMAL 99 0.0065
278 BLOOD UREA INCREASED 108 0.0064
279 GENERAL PHYSICAL HEALTH DETERIORATION 743 0.0064
280 ANGINA PECTORIS 184 0.0064
281 VITAMIN B12 DEFICIENCY 26 0.0064
282 HYDRONEPHROSIS 48 0.0064
283 RENAL FAILURE 849 0.0064
284 UNEVALUABLE EVENT 482 0.0064
285 GOITRE 26 0.0063
286 FULL BLOOD COUNT ABNORMAL 67 0.0063
287 LEUKOPENIA 315 0.0063
288 OEDEMA PERIPHERAL 764 0.0063
289 FEMORAL NECK FRACTURE 32 0.0062
290 RENAL FAILURE ACUTE 264 0.0062
291 GENERALISED OEDEMA 77 0.0062
292 WOUND DEHISCENCE 21 0.0062
293 PERIPHERAL VASCULAR DISORDER 32 0.0062
294 DEFORMITY 58 0.0062
295 HAEMORRHOIDS 119 0.0061
296 ACUTE MYELOID LEUKAEMIA 95 0.0061
297 ESCHERICHIA INFECTION 50 0.0061
298 HOSPICE CARE 60 0.0061
299 SKIN ULCER 157 0.0061
300 UROSEPSIS 56 0.0061
301 PHLEBITIS 31 0.0060
302 CARDIAC PACEMAKER INSERTION 36 0.0060
303 PRODUCT TEMPERATURE EXCURSION ISSUE 31 0.0060
304 BLOOD DISORDER 48 0.0060
305 MALNUTRITION 67 0.0060
306 CELLULITIS 301 0.0060
307 HYPOALBUMINAEMIA 46 0.0059
308 FLANK PAIN 55 0.0059
309 MATERNAL EXPOSURE TIMING UNSPECIFIED 22 0.0059
310 OSTEONECROSIS OF JAW 144 0.0058
311 PROTEIN URINE PRESENT 29 0.0058
312 BLOOD IRON DECREASED 69 0.0058
313 TOXIC SKIN ERUPTION 58 0.0058
314 BLOOD PHOSPHORUS DECREASED 21 0.0057
315 DISEASE COMPLICATION 26 0.0057
316 MICTURITION URGENCY 64 0.0056
317 PROTEIN TOTAL DECREASED 21 0.0056
318 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 291 0.0056
319 ACUTE CORONARY SYNDROME 46 0.0055
320 PERITONITIS BACTERIAL 56 0.0055
321 METASTASES TO BONE 91 0.0055
322 RED CELL DISTRIBUTION WIDTH INCREASED 23 0.0055
323 GLOMERULAR FILTRATION RATE DECREASED 68 0.0055
324 SPINAL COLUMN STENOSIS 26 0.0055
325 PRE-ECLAMPSIA 26 0.0055
326 ONYCHOMYCOSIS 24 0.0055
327 TOOTH EXTRACTION 68 0.0055
328 MYOCARDIAL ISCHAEMIA 62 0.0054
329 THROMBOSIS 438 0.0054
330 RENAL TUBULAR NECROSIS 53 0.0054
331 CARDIOPULMONARY FAILURE 21 0.0054
332 LUNG NEOPLASM 23 0.0054
333 URINE OUTPUT DECREASED 47 0.0054
334 HYPOGAMMAGLOBULINAEMIA 35 0.0053
335 INCORRECT PRODUCT STORAGE 70 0.0053
336 RENAL CELL CARCINOMA 26 0.0053
337 LEUKOCYTOSIS 96 0.0053
338 GINGIVAL PAIN 42 0.0053
339 PROTEINURIA 100 0.0053
340 TRANSIENT ISCHAEMIC ATTACK 176 0.0052
341 HYPERTENSIVE CRISIS 58 0.0052
342 PURPURA 46 0.0052
343 EOSINOPHILIA 91 0.0052
344 HEPATOMEGALY 51 0.0052
345 COLITIS ISCHAEMIC 35 0.0052
346 HIATUS HERNIA 67 0.0052
347 SCOLIOSIS 32 0.0052
348 BRONCHOPULMONARY ASPERGILLOSIS 40 0.0052
349 DIABETES MELLITUS 392 0.0051
350 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 49 0.0051
351 PSEUDOMONAS INFECTION 44 0.0051
352 THROMBOTIC MICROANGIOPATHY 50 0.0051
353 PULMONARY MASS 76 0.0051
354 CHRONIC KIDNEY DISEASE 386 0.0051
355 ISCHAEMIC STROKE 90 0.0050
356 COMPRESSION FRACTURE 27 0.0050
357 HEPATIC CYTOLYSIS 64 0.0050
358 C-REACTIVE PROTEIN INCREASED 181 0.0050
359 SUBDURAL HAEMATOMA 71 0.0050
360 URINE ODOUR ABNORMAL 29 0.0049
361 PERFORMANCE STATUS DECREASED 23 0.0049
362 NO THERAPEUTIC RESPONSE 60 0.0049
363 DECREASED INTEREST 29 0.0049
364 PURULENT DISCHARGE 21 0.0049
365 STAPHYLOCOCCAL INFECTION 162 0.0049
366 INTESTINAL ISCHAEMIA 27 0.0049
367 ATRIAL FLUTTER 39 0.0049
368 ACUTE MYOCARDIAL INFARCTION 144 0.0049
369 CARDIAC FAILURE CONGESTIVE 391 0.0049
370 PULMONARY EMBOLISM 462 0.0049
371 PERICARDIAL EFFUSION 112 0.0048
372 EMBOLISM 40 0.0048
373 PULMONARY OEDEMA 215 0.0048
374 SHOCK HAEMORRHAGIC 39 0.0048
375 FULL BLOOD COUNT DECREASED 96 0.0048
376 FLUID RETENTION 242 0.0048
377 LOCALISED OEDEMA 22 0.0047
378 PULMONARY HYPERTENSION 99 0.0047
379 PREMATURE BABY 143 0.0047
380 JAW DISORDER 26 0.0047
381 SKIN PLAQUE 40 0.0047
382 SUDDEN DEATH 50 0.0047
383 UMBILICAL HERNIA 22 0.0047
384 FRACTURE 89 0.0047
385 KIDNEY INFECTION 92 0.0047
386 ENTEROCOLITIS 27 0.0047
387 NEPHROTIC SYNDROME 32 0.0047
388 PNEUMONIA 1504 0.0046
389 HAEMATOMA 120 0.0046
390 ANEURYSM 23 0.0046
391 ABDOMINAL HERNIA 21 0.0046
392 BONE CANCER 20 0.0046
393 HAEMOPTYSIS 128 0.0046
394 DEEP VEIN THROMBOSIS 298 0.0046
395 HAEMOLYTIC ANAEMIA 41 0.0046
396 METABOLIC ACIDOSIS 146 0.0046
397 SKIN HYPERPIGMENTATION 39 0.0045
398 HYPERKERATOSIS 25 0.0045
399 ARTERIOSCLEROSIS CORONARY ARTERY 30 0.0045
400 HYPOMAGNESAEMIA 63 0.0045
401 PRESYNCOPE 110 0.0045
402 TENDERNESS 47 0.0045
403 MENTAL STATUS CHANGES 125 0.0045
404 METASTASES TO LUNG 52 0.0045
405 HEPATITIS B 27 0.0045
406 PLATELET COUNT ABNORMAL 27 0.0045
407 OEDEMA 242 0.0045
408 URINARY TRACT INFECTION 760 0.0045
409 ABDOMINAL DISTENSION 465 0.0045
410 CYTOMEGALOVIRUS INFECTION 74 0.0044
411 CARDIOVASCULAR DISORDER 113 0.0044
412 HEPATOCELLULAR INJURY 63 0.0044
413 DYSPNOEA EXERTIONAL 167 0.0044
414 INTERVERTEBRAL DISC DEGENERATION 41 0.0044
415 DENTAL CARIES 49 0.0044
416 POLYNEUROPATHY 53 0.0044
417 MYOPATHY 38 0.0044
418 CORONARY ARTERY DISEASE 133 0.0044
419 SUBCUTANEOUS ABSCESS 21 0.0044
420 ODYNOPHAGIA 26 0.0044
421 HUMERUS FRACTURE 21 0.0044
422 BLOOD LACTATE DEHYDROGENASE INCREASED 69 0.0044
423 LEUKAEMIA 41 0.0043
424 CARDIOMYOPATHY 64 0.0043
425 ABSCESS 69 0.0043
426 HEPATITIS CHOLESTATIC 26 0.0043
427 EMPHYSEMA 43 0.0043
428 JOINT INJURY 91 0.0043
429 MYOSITIS 38 0.0042
430 PLATELET COUNT DECREASED 447 0.0042
431 CHOLANGITIS 26 0.0042
432 SUPRAVENTRICULAR TACHYCARDIA 40 0.0042
433 JOINT RANGE OF MOTION DECREASED 56 0.0042
434 BASAL CELL CARCINOMA 65 0.0042
435 CHOLESTASIS 80 0.0042
436 UPPER GASTROINTESTINAL HAEMORRHAGE 70 0.0042
437 DEHYDRATION 553 0.0041
438 PLATELET COUNT INCREASED 54 0.0041
439 SWELLING OF EYELID 26 0.0041
440 INTERNATIONAL NORMALISED RATIO INCREASED 117 0.0041
441 METASTASES TO LIVER 72 0.0041
442 OSTEOPENIA 62 0.0041
443 NEPHROPATHY 38 0.0041
444 BLOOD ALKALINE PHOSPHATASE INCREASED 101 0.0041
445 NEOPLASM MALIGNANT 271 0.0041
446 CEREBRAL INFARCTION 99 0.0040
447 LYMPHOEDEMA 28 0.0040
448 CARDIAC ARREST 334 0.0040
449 METASTASES TO CENTRAL NERVOUS SYSTEM 52 0.0040
450 TOOTH ABSCESS 41 0.0040
451 SPUTUM DISCOLOURED 38 0.0040
452 TRANSAMINASES INCREASED 89 0.0040
453 TUMOUR LYSIS SYNDROME 35 0.0040
454 VITAMIN D DECREASED 34 0.0040
455 SEPTIC SHOCK 173 0.0040
456 MUCOSAL INFLAMMATION 104 0.0040
457 SCAR 68 0.0040
458 HYPERTENSION 840 0.0040
459 ORTHOSTATIC HYPOTENSION 69 0.0040
460 CHOLECYSTITIS 47 0.0039
461 WALKING AID USER 26 0.0039
462 HYPOKALAEMIA 182 0.0039
463 ATRIAL FIBRILLATION 383 0.0039
464 CARDIAC MURMUR 34 0.0039
465 LUNG INFECTION 61 0.0039
466 BLOOD CHOLESTEROL INCREASED 183 0.0039
467 ANGIOPATHY 22 0.0039
468 GASTROINTESTINAL HAEMORRHAGE 328 0.0039
469 RASH MACULO-PAPULAR 87 0.0039
470 PLASMA CELL MYELOMA 152 0.0039
471 ANOREXIA 50 0.0039
472 PLEURISY 23 0.0039
473 NEUTROPENIA 526 0.0039
474 VASCULITIS 45 0.0039
475 EPISTAXIS 287 0.0038
476 INFECTION 555 0.0038
477 GENERAL PHYSICAL CONDITION ABNORMAL 26 0.0038
478 CORONARY ARTERY BYPASS 22 0.0038
479 BLOOD MAGNESIUM DECREASED 33 0.0038
480 MULTI-ORGAN FAILURE 66 0.0038
481 MUSCULOSKELETAL CHEST PAIN 59 0.0038
482 MELAENA 83 0.0038
483 COLON CANCER 56 0.0038
484 GROIN PAIN 33 0.0038
485 OESOPHAGITIS 41 0.0037
486 ABDOMINAL PAIN 871 0.0037
487 INTENTIONAL PRODUCT MISUSE 327 0.0037
488 HYPOPHAGIA 95 0.0037
489 CLOSTRIDIUM DIFFICILE INFECTION 81 0.0037
490 PERONEAL NERVE PALSY 21 0.0037
491 SWELLING 344 0.0037
492 ACUTE KIDNEY INJURY 562 0.0037
493 CANDIDA INFECTION 62 0.0037
494 ACIDOSIS 28 0.0037
495 FALL 1218 0.0037
496 GASTRIC HAEMORRHAGE 42 0.0036
497 HYPOXIA 128 0.0036
498 EXOSTOSIS 33 0.0036
499 CARDIAC OPERATION 31 0.0036
500 EOSINOPHIL COUNT INCREASED 30 0.0036
501 LOCALISED INFECTION 87 0.0036
502 RECTAL HAEMORRHAGE 154 0.0036
503 PEMPHIGOID 27 0.0036
504 RASH PUSTULAR 26 0.0036
505 WOUND INFECTION 39 0.0036
506 FEBRILE NEUTROPENIA 236 0.0036
507 UPPER RESPIRATORY TRACT INFECTION 164 0.0035
508 CONSTIPATION 773 0.0035
509 OLIGURIA 22 0.0035
510 STATUS EPILEPTICUS 40 0.0035
511 HERPES SIMPLEX 23 0.0035
512 BONE PAIN 207 0.0035
513 HYPOGLYCAEMIA 171 0.0035
514 GASTRIC ULCER 67 0.0035
515 OSTEONECROSIS 115 0.0035
516 RIB FRACTURE 72 0.0035
517 HEPATIC STEATOSIS 65 0.0035
518 SECOND PRIMARY MALIGNANCY 29 0.0035
519 PNEUMOCYSTIS JIROVECII PNEUMONIA 35 0.0035
520 PNEUMONIA ASPIRATION 87 0.0035
521 INTESTINAL PERFORATION 39 0.0035
522 DEMENTIA 97 0.0035
523 LUNG DISORDER 170 0.0035
524 SKIN LESION 95 0.0035
525 DISEASE PROGRESSION 409 0.0035
526 ATRIOVENTRICULAR BLOCK COMPLETE 23 0.0034
527 LEFT VENTRICULAR DYSFUNCTION 23 0.0034
528 PULMONARY CONGESTION 45 0.0034
529 INTERNAL HAEMORRHAGE 39 0.0034
530 POSTOPERATIVE WOUND INFECTION 23 0.0034
531 BLOOD PRESSURE FLUCTUATION 81 0.0034
532 PAIN IN JAW 95 0.0034
533 JAUNDICE 90 0.0033
534 HYPOTENSION 659 0.0033
535 RIGHT VENTRICULAR FAILURE 23 0.0033
536 BLOOD PRESSURE ABNORMAL 65 0.0033
537 CYTOPENIA 40 0.0033
538 RETINAL HAEMORRHAGE 23 0.0032
539 ILEUS 40 0.0032
540 SQUAMOUS CELL CARCINOMA 30 0.0032
541 HYPERBILIRUBINAEMIA 33 0.0032
542 VIRAL INFECTION 106 0.0032
543 PULMONARY FIBROSIS 61 0.0032
544 BLOOD PRESSURE SYSTOLIC INCREASED 62 0.0032
545 CAESAREAN SECTION 37 0.0032
546 PERITONEAL DIALYSIS COMPLICATION 23 0.0032
547 TUBULOINTERSTITIAL NEPHRITIS 59 0.0031
548 BLOOD SODIUM DECREASED 59 0.0031
549 RESPIRATORY DISTRESS 86 0.0031
550 UPPER LIMB FRACTURE 62 0.0031
551 CHOLELITHIASIS 102 0.0031
552 CARDIAC DISORDER 290 0.0031
553 SINUS TACHYCARDIA 44 0.0031
554 BRAIN INJURY 31 0.0031
555 RESPIRATORY FAILURE 225 0.0031
556 GALLBLADDER DISORDER 55 0.0031
557 ASTHENIA 1157 0.0031
558 MASS 43 0.0031
559 HAEMORRHAGIC STROKE 24 0.0031
560 PHARYNGITIS 38 0.0031
561 OBSTRUCTIVE AIRWAYS DISORDER 34 0.0031
562 ANHEDONIA 80 0.0030
563 SUBARACHNOID HAEMORRHAGE 31 0.0030
564 LYMPHOMA 47 0.0030
565 GASTRITIS 80 0.0030
566 LARGE INTESTINE PERFORATION 21 0.0030
567 MUSCULOSKELETAL PAIN 158 0.0030
568 IMPAIRED HEALING 99 0.0030
569 EYELID OEDEMA 35 0.0030
570 DRY MOUTH 244 0.0030
571 OFF LABEL USE 2624 0.0030
572 THERAPY NON-RESPONDER 134 0.0030
573 BLOOD PRESSURE DIASTOLIC DECREASED 22 0.0030
574 NEUROPATHY PERIPHERAL 283 0.0030
575 DRUG INTOLERANCE 287 0.0030
576 PYREXIA 1027 0.0030
577 EJECTION FRACTION DECREASED 46 0.0030
578 LIVER DISORDER 131 0.0030
579 COAGULOPATHY 49 0.0029
580 PULMONARY HAEMORRHAGE 23 0.0029
581 FISTULA 33 0.0029
582 GINGIVAL BLEEDING 40 0.0029
583 ELECTROLYTE IMBALANCE 34 0.0029
584 POST PROCEDURAL COMPLICATION 56 0.0029
585 HAEMORRHAGE 304 0.0029
586 WHITE BLOOD CELL COUNT DECREASED 315 0.0029
587 ANURIA 25 0.0029
588 DERMATITIS BULLOUS 21 0.0029
589 ASPARTATE AMINOTRANSFERASE INCREASED 154 0.0029
590 LYMPHOPENIA 41 0.0029
591 INTERVERTEBRAL DISC PROTRUSION 63 0.0029
592 LABORATORY TEST ABNORMAL 85 0.0029
593 ORAL PAIN 64 0.0029
594 STENT PLACEMENT 23 0.0028
595 SMALL INTESTINAL OBSTRUCTION 35 0.0028
596 RESTLESS LEGS SYNDROME 51 0.0028
597 CEREBRAL HAEMORRHAGE 100 0.0028
598 WHITE BLOOD CELL COUNT INCREASED 107 0.0028
599 PSYCHOLOGICAL TRAUMA 24 0.0028
600 PETECHIAE 29 0.0028
601 GAMMA-GLUTAMYLTRANSFERASE INCREASED 61 0.0027
602 LYMPHADENOPATHY 97 0.0027
603 FACE OEDEMA 46 0.0027
604 PNEUMONIA BACTERIAL 25 0.0027
605 TOOTH FRACTURE 30 0.0027
606 TOOTHACHE 49 0.0027
607 ARRHYTHMIA 128 0.0027
608 CIRCULATORY COLLAPSE 46 0.0027
609 HEPATIC ENCEPHALOPATHY 25 0.0027
610 GASTROINTESTINAL INFECTION 24 0.0027
611 ELECTROCARDIOGRAM ABNORMAL 21 0.0027
612 RASH GENERALISED 69 0.0027
613 ENCEPHALOPATHY 65 0.0026
614 CONFUSIONAL STATE 426 0.0026
615 SLEEP DISORDER 186 0.0026
616 AORTIC ANEURYSM 20 0.0026
617 CYSTITIS 83 0.0026
618 BRONCHITIS 192 0.0026
619 ABASIA 64 0.0026
620 HYPERGLYCAEMIA 94 0.0026
621 DYSPNOEA 1458 0.0026
622 TOXIC EPIDERMAL NECROLYSIS 39 0.0026
623 HYPOTHERMIA 26 0.0026
624 LACERATION 24 0.0025
625 HIP ARTHROPLASTY 39 0.0025
626 BLOOD PRESSURE INCREASED 389 0.0025
627 BREAST CANCER METASTATIC 27 0.0025
628 CHEST PAIN 465 0.0025
629 BRADYCARDIA 133 0.0025
630 HEPATIC FAILURE 75 0.0025
631 DISSEMINATED INTRAVASCULAR COAGULATION 35 0.0025
632 DRUG ERUPTION 44 0.0025
633 PALLOR 67 0.0025
634 JOINT DISLOCATION 26 0.0025
635 RESPIRATORY TRACT INFECTION 64 0.0025
636 ANKLE FRACTURE 38 0.0025
637 LIVER FUNCTION TEST ABNORMAL 71 0.0024
638 MOBILITY DECREASED 175 0.0024
639 CATARACT 145 0.0024
640 VOMITING 1144 0.0024
641 ORAL CANDIDIASIS 32 0.0024
642 SYNCOPE 243 0.0024
643 CARPAL TUNNEL SYNDROME 34 0.0024
644 BODY TEMPERATURE INCREASED 49 0.0024
645 MYOCARDIAL INFARCTION 418 0.0024
646 OSTEOARTHRITIS 101 0.0024
647 DIVERTICULITIS 66 0.0024
648 SINUS BRADYCARDIA 23 0.0024
649 HERPES ZOSTER 136 0.0024
650 HAEMATEMESIS 60 0.0024
651 BLOOD POTASSIUM DECREASED 71 0.0024
652 BEDRIDDEN 31 0.0024
653 NEUTROPHIL COUNT INCREASED 24 0.0023
654 HEPATIC CIRRHOSIS 44 0.0023
655 DYSURIA 86 0.0023
656 FEMUR FRACTURE 72 0.0023
657 SKIN INFECTION 26 0.0023
658 BLADDER DISORDER 23 0.0023
659 VENTRICULAR EXTRASYSTOLES 24 0.0023
660 SPINAL FRACTURE 46 0.0023
661 CONTUSION 221 0.0023
662 SURGERY 134 0.0023
663 INCONTINENCE 24 0.0023
664 PNEUMOTHORAX 36 0.0023
665 LYMPHOCYTE COUNT DECREASED 40 0.0023
666 LUNG NEOPLASM MALIGNANT 93 0.0023
667 DIABETES MELLITUS INADEQUATE CONTROL 40 0.0023
668 CARDIO-RESPIRATORY ARREST 94 0.0022
669 QUALITY OF LIFE DECREASED 30 0.0022
670 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 52 0.0022
671 SWELLING FACE 145 0.0022
672 NOCTURIA 27 0.0022
673 POOR VENOUS ACCESS 23 0.0022
674 MALAISE 974 0.0022
675 DEAFNESS 58 0.0022
676 LETHARGY 127 0.0022
677 PNEUMONITIS 60 0.0022
678 DELIRIUM 76 0.0022
679 CONVULSION 125 0.0022
680 ROTATOR CUFF SYNDROME 28 0.0022
681 VENTRICULAR TACHYCARDIA 36 0.0022
682 NEOPLASM 25 0.0022
683 GASTROOESOPHAGEAL REFLUX DISEASE 175 0.0022
684 PRURITUS GENERALISED 47 0.0022
685 DECREASED APPETITE 499 0.0021
686 LIVER FUNCTION TEST INCREASED 46 0.0021
687 BLOOD PRESSURE DECREASED 142 0.0021
688 HEMIPARESIS 36 0.0021
689 WOUND 59 0.0021
690 MALIGNANT NEOPLASM PROGRESSION 215 0.0021
691 CEREBROVASCULAR ACCIDENT 355 0.0021
692 HEAD INJURY 66 0.0021
693 DIARRHOEA 1339 0.0021
694 DRUG TOXICITY 28 0.0021
695 NEPHROPATHY TOXIC 23 0.0020
696 SKIN DISCOLOURATION 94 0.0020
697 MOUTH ULCERATION 43 0.0020
698 CHILLS 239 0.0020
699 INTERSTITIAL LUNG DISEASE 98 0.0020
700 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 52 0.0020
701 URINARY RETENTION 67 0.0020
702 THERAPY PARTIAL RESPONDER 31 0.0020
703 RENAL INJURY 59 0.0020
704 BURSITIS 24 0.0020
705 POST PROCEDURAL HAEMORRHAGE 23 0.0020
706 ILL-DEFINED DISORDER 120 0.0020
707 RESTLESSNESS 72 0.0020
708 NEUTROPHIL COUNT DECREASED 80 0.0020
709 STOMATITIS 119 0.0020
710 BACK PAIN 455 0.0020
711 VISUAL ACUITY REDUCED 65 0.0020
712 LOCAL SWELLING 34 0.0019
713 BLOOD URINE PRESENT 37 0.0019
714 COVID-19 PNEUMONIA 23 0.0019
715 TOOTH LOSS 40 0.0019
716 ACUTE RESPIRATORY FAILURE 37 0.0019
717 FATIGUE 1491 0.0019
718 PANCREATITIS ACUTE 43 0.0019
719 FOOT FRACTURE 36 0.0019
720 RED BLOOD CELL SEDIMENTATION RATE INCREASED 21 0.0019
721 OSTEOPOROSIS 78 0.0019
722 INJURY 133 0.0019
723 PRODUCTIVE COUGH 90 0.0019
724 SCIATICA 30 0.0019
725 EYE HAEMORRHAGE 25 0.0019
726 HAEMORRHAGE INTRACRANIAL 28 0.0019
727 RHABDOMYOLYSIS 78 0.0019
728 EPILEPSY 57 0.0019
729 SOMNOLENCE 375 0.0019
730 INFLAMMATION 96 0.0019
731 UNRESPONSIVE TO STIMULI 48 0.0019
732 DYSARTHRIA 70 0.0019
733 INTESTINAL OBSTRUCTION 70 0.0019
734 MUSCULAR WEAKNESS 211 0.0019
735 ADVERSE EVENT 171 0.0019
736 MUSCULOSKELETAL STIFFNESS 162 0.0018
737 ALTERED STATE OF CONSCIOUSNESS 40 0.0018
738 DYSPHAGIA 175 0.0018
739 OXYGEN SATURATION DECREASED 103 0.0018
740 COLITIS 69 0.0018
741 BLOOD BILIRUBIN INCREASED 49 0.0018
742 FEELING COLD 50 0.0018
743 LOSS OF CONSCIOUSNESS 230 0.0018
744 DRUG RESISTANCE 46 0.0018
745 WEIGHT DECREASED 499 0.0018
746 MUSCULOSKELETAL DISORDER 34 0.0018
747 NEEDLE ISSUE 52 0.0018
748 HYPOTHYROIDISM 57 0.0018
749 NIGHT SWEATS 57 0.0018
750 DISORIENTATION 70 0.0018
751 MYOCLONUS 21 0.0018
752 URINARY INCONTINENCE 52 0.0018
753 MATERNAL EXPOSURE DURING PREGNANCY 155 0.0017
754 TACHYCARDIA 154 0.0017
755 CONDITION AGGRAVATED 525 0.0017
756 PERICARDITIS 29 0.0017
757 DEPRESSED LEVEL OF CONSCIOUSNESS 68 0.0017
758 MALIGNANT MELANOMA 23 0.0017
759 TOOTH DISORDER 38 0.0017
760 GLYCOSYLATED HAEMOGLOBIN INCREASED 43 0.0017
761 ACUTE RESPIRATORY DISTRESS SYNDROME 30 0.0017
762 SKIN FISSURES 33 0.0017
763 IMPAIRED GASTRIC EMPTYING 23 0.0017
764 MUSCULOSKELETAL DISCOMFORT 29 0.0017
765 HEART RATE IRREGULAR 38 0.0017
766 JOINT STIFFNESS 44 0.0017
767 PERIPHERAL COLDNESS 23 0.0017
768 FEAR 45 0.0017
769 COUGH 469 0.0017
770 SINUS DISORDER 33 0.0017
771 SARS-COV-2 TEST POSITIVE 22 0.0017
772 VERTIGO 101 0.0017
773 LIMB INJURY 45 0.0017
774 NAUSEA 1309 0.0017
775 CYANOSIS 26 0.0017
776 COMPLICATION ASSOCIATED WITH DEVICE 24 0.0017
777 SICKLE CELL ANAEMIA WITH CRISIS 26 0.0016
778 EATING DISORDER 35 0.0016
779 RASH ERYTHEMATOUS 78 0.0016
780 DRUG LEVEL INCREASED 27 0.0016
781 TENDONITIS 25 0.0016
782 NODULE 21 0.0016
783 EAR PAIN 31 0.0016
784 TOOTH INFECTION 21 0.0016
785 ORAL HERPES 31 0.0016
786 PULMONARY ARTERIAL HYPERTENSION 23 0.0016
787 GASTROINTESTINAL DISORDER 142 0.0016
788 DEVICE OCCLUSION 22 0.0016
789 LOWER LIMB FRACTURE 30 0.0016
790 RASH PRURITIC 84 0.0015
791 COMA 73 0.0015
792 PANCREATITIS 81 0.0015
793 FAECES DISCOLOURED 33 0.0015
794 NECK PAIN 85 0.0015
795 SLEEP APNOEA SYNDROME 29 0.0015
796 DISABILITY 30 0.0015
797 HAEMATOCHEZIA 83 0.0015
798 WHEEZING 89 0.0015
799 HERNIA 29 0.0015
800 BLOOD CREATINE PHOSPHOKINASE INCREASED 43 0.0015
801 POLLAKIURIA 62 0.0015
802 LIMB DISCOMFORT 46 0.0015
803 NEUROTOXICITY 26 0.0015
804 TREATMENT NONCOMPLIANCE 81 0.0015
805 DRUG INTERACTION 234 0.0015
806 ABDOMINAL PAIN LOWER 37 0.0015
807 BLOOD GLUCOSE ABNORMAL 27 0.0015
808 NEPHROLITHIASIS 67 0.0015
809 APHASIA 44 0.0015
810 ECONOMIC PROBLEM 22 0.0015
811 ALANINE AMINOTRANSFERASE INCREASED 89 0.0014
812 RESPIRATORY DISORDER 43 0.0014
813 SHOCK 33 0.0014
814 DERMATITIS 30 0.0014
815 GLAUCOMA 27 0.0014
816 BRONCHOSPASM 20 0.0014
817 BONE LOSS 21 0.0014
818 PAIN IN EXTREMITY 406 0.0014
819 HYPOAESTHESIA 206 0.0014
820 PERIPHERAL SWELLING 212 0.0014
821 GAIT DISTURBANCE 261 0.0014
822 PAIN 837 0.0014
823 HYPERSOMNIA 39 0.0014
824 MUSCLE TIGHTNESS 22 0.0014
825 DIPLOPIA 35 0.0013
826 GASTRIC DISORDER 46 0.0013
827 HEPATIC FUNCTION ABNORMAL 50 0.0013
828 COVID-19 234 0.0013
829 TREMOR 221 0.0013
830 HALLUCINATION, VISUAL 28 0.0013
831 BLOOD GLUCOSE DECREASED 63 0.0013
832 MYALGIA 222 0.0013
833 FOETAL EXPOSURE DURING PREGNANCY 106 0.0013
834 DIZZINESS 649 0.0013
835 ERYTHEMA 266 0.0013
836 CHROMATURIA 29 0.0013
837 PARAESTHESIA 202 0.0013
838 FEEDING DISORDER 26 0.0013
839 SKIN EXFOLIATION 108 0.0013
840 ANAPHYLACTIC SHOCK 33 0.0013
841 GASTROENTERITIS VIRAL 23 0.0013
842 ANXIETY 361 0.0013
843 LACTIC ACIDOSIS 41 0.0013
844 NEOPLASM PROGRESSION 44 0.0013
845 INFLUENZA 141 0.0013
846 ACTIVITIES OF DAILY LIVING IMPAIRED 25 0.0013
847 STEVENS-JOHNSON SYNDROME 28 0.0013
848 RASH MACULAR 44 0.0013
849 HEART RATE DECREASED 44 0.0013
850 HEPATITIS 32 0.0012
851 BALANCE DISORDER 108 0.0012
852 ABDOMINAL PAIN UPPER 255 0.0012
853 PRODUCT ADMINISTRATION ERROR 25 0.0012
854 BLISTER 69 0.0012
855 BLINDNESS 50 0.0012
856 SPEECH DISORDER 64 0.0012
857 CHEST DISCOMFORT 125 0.0012
858 SYNOVITIS 22 0.0012
859 RETCHING 26 0.0012
860 EMOTIONAL DISTRESS 146 0.0012
861 SKIN DISORDER 40 0.0012
862 CYTOKINE RELEASE SYNDROME 24 0.0012
863 ELECTROCARDIOGRAM QT PROLONGED 43 0.0012
864 ARTHROPATHY 66 0.0012
865 CONJUNCTIVITIS 22 0.0012
866 EYE SWELLING 44 0.0012
867 DRUG EFFECT DECREASED 63 0.0012
868 SKIN CANCER 25 0.0012
869 ASTHMA 131 0.0012
870 RASH 504 0.0012
871 OROPHARYNGEAL PAIN 107 0.0012
872 NERVOUS SYSTEM DISORDER 36 0.0012
873 MUSCLE SPASMS 211 0.0011
874 FUNGAL INFECTION 38 0.0011
875 HEART RATE INCREASED 112 0.0011
876 DRUG EFFECT INCOMPLETE 41 0.0011
877 DYSPHONIA 65 0.0011
878 GASTRIC CANCER 28 0.0011
879 ARTHRALGIA 458 0.0011
880 DYSSTASIA 32 0.0011
881 GAIT INABILITY 36 0.0011
882 ECZEMA 56 0.0011
883 HYPOACUSIS 46 0.0011
884 RHINORRHOEA 69 0.0011
885 PALPITATIONS 125 0.0011
886 PRURITUS 407 0.0011
887 ARTHRITIS 83 0.0011
888 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 75 0.0011
889 RESPIRATORY ARREST 28 0.0010
890 DEVICE DIFFICULT TO USE 67 0.0010
891 PAIN OF SKIN 27 0.0010
892 NASOPHARYNGITIS 184 0.0010
893 SEIZURE 115 0.0010
894 SWOLLEN TONGUE 31 0.0010
895 HEADACHE 608 0.0010
896 INSOMNIA 258 0.0010
897 AMNESIA 63 0.0010
898 EXPOSURE DURING PREGNANCY 60 0.0010
899 ACCIDENTAL EXPOSURE TO PRODUCT 99 0.0010
900 MENTAL IMPAIRMENT 23 0.0009
901 DYSPEPSIA 93 0.0009
902 DRUG DOSE OMISSION 155 0.0009
903 JOINT SWELLING 112 0.0009
904 LACRIMATION INCREASED 28 0.0009
905 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 186 0.0009
906 FEELING ABNORMAL 219 0.0009
907 HYPERHIDROSIS 117 0.0009
908 DEPRESSION 205 0.0009
909 PANCREATIC CARCINOMA 26 0.0009
910 PRODUCT USE IN UNAPPROVED INDICATION 223 0.0009
911 EYE DISORDER 29 0.0009
912 PRODUCT PRESCRIBING ERROR 21 0.0009
913 HYPERSENSITIVITY 162 0.0009
914 LIP SWELLING 29 0.0009
915 DISCOMFORT 53 0.0009
916 VISION BLURRED 119 0.0009
917 ALOPECIA 170 0.0009
918 EAR INFECTION 23 0.0009
919 ROAD TRAFFIC ACCIDENT 36 0.0009
920 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 61 0.0009
921 BURNING SENSATION 60 0.0009
922 NO ADVERSE EVENT 154 0.0008
923 DYSGEUSIA 63 0.0008
924 ABDOMINAL DISCOMFORT 142 0.0008
925 COGNITIVE DISORDER 39 0.0008
926 ANAPHYLACTIC REACTION 46 0.0008
927 TINNITUS 38 0.0008
928 INFLUENZA LIKE ILLNESS 68 0.0008
929 ADVERSE DRUG REACTION 73 0.0008
930 BLOOD GLUCOSE INCREASED 153 0.0008
931 MEDICATION ERROR 45 0.0008
932 INTENTIONAL PRODUCT USE ISSUE 70 0.0008
933 ACCIDENTAL OVERDOSE 29 0.0008
934 URTICARIA 132 0.0008
935 DISEASE RECURRENCE 37 0.0008
936 TYPE 2 DIABETES MELLITUS 26 0.0008
937 SINUSITIS 79 0.0008
938 HALLUCINATION 58 0.0008
939 OVERDOSE 166 0.0008
940 FEELING HOT 47 0.0008
941 NASAL CONGESTION 45 0.0008
942 MENTAL DISORDER 33 0.0008
943 FLATULENCE 43 0.0008
944 INFUSION RELATED REACTION 50 0.0008
945 MYELOSUPPRESSION 27 0.0007
946 DRUG ADMINISTRATION ERROR 23 0.0007
947 NERVOUSNESS 39 0.0007
948 ANGIOEDEMA 33 0.0007
949 WEIGHT INCREASED 166 0.0007
950 AGITATION 54 0.0007
951 MEMORY IMPAIRMENT 99 0.0007
952 INJECTION SITE PAIN 219 0.0007
953 DRUG INEFFECTIVE 929 0.0007
954 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 127 0.0007
955 HOT FLUSH 53 0.0007
956 EXPIRED PRODUCT ADMINISTERED 23 0.0007
957 TREATMENT FAILURE 54 0.0007
958 PROSTATE CANCER 52 0.0006
959 INCORRECT ROUTE OF DRUG ADMINISTRATION 23 0.0006
960 PRODUCT DOSE OMISSION 42 0.0006
961 VISUAL IMPAIRMENT 77 0.0006
962 TOXICITY TO VARIOUS AGENTS 104 0.0006
963 DYSKINESIA 25 0.0006
964 DRY SKIN 81 0.0006
965 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 29 0.0006
966 VAGINAL HAEMORRHAGE 26 0.0006
967 SYSTEMIC LUPUS ERYTHEMATOSUS 21 0.0006
968 THERAPY INTERRUPTED 42 0.0006
969 HEPATIC ENZYME INCREASED 40 0.0006
970 ILLNESS 60 0.0006
971 INCORRECT DOSE ADMINISTERED 128 0.0006
972 DISTURBANCE IN ATTENTION 30 0.0006
973 DEPRESSED MOOD 29 0.0005
974 RENAL CANCER 26 0.0005
975 FLUSHING 54 0.0005
976 INJECTION SITE REACTION 36 0.0005
977 THERAPY CESSATION 26 0.0005
978 ABNORMAL BEHAVIOUR 20 0.0005
979 DEVICE ISSUE 45 0.0005
980 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 27 0.0005
981 PRODUCT DOSE OMISSION ISSUE 144 0.0005
982 DRUG DOSE OMISSION BY DEVICE 38 0.0005
983 BLADDER CANCER 28 0.0005
984 UNDERDOSE 34 0.0005
985 OCULAR HYPERAEMIA 21 0.0004
986 PRODUCT USE ISSUE 81 0.0004
987 MIGRAINE 39 0.0004
988 BREAST CANCER 37 0.0004
989 INJECTION SITE BRUISING 31 0.0004
990 EYE PAIN 21 0.0004
991 INJECTION SITE HAEMORRHAGE 28 0.0004
992 SKIN BURNING SENSATION 24 0.0003
993 RHEUMATOID ARTHRITIS 32 0.0003
994 PSORIASIS 35 0.0003
995 INJECTION SITE ERYTHEMA 23 0.0002